Pulmonary rehabilitation for patients with advanced lung cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effects of a pulmonary rehabilitation program on patients with advanced non-small cell lung cancer. Participants will be randomized into an intervention group, receiving 12 sessions of pulmonary rehabilitation over 4-6 weeks, or a control group, receiving general recommendations for physical activity. The study will assess improvements in pulmonary function, muscle mass, exercise tolerance, inflammatory response, quality of life, and overall survival. Nutritional assessments and interventions will also be provided to both groups as needed.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Confirmed diagnosis of advanced non-small-cell lung cancer
* Good performance status (ECOG 0-1)
* Life expectancy \>12 weeks
* Eligible to receive treatment with chemotherapy or tyrosinkinase inhibitors
* Recent electrocardiogram without evidence of arrythmia

Exclusion Criteria:

* Symptomatic brain metastasis
* Uncontrolled pain (Visual Analog Scale \>5)
* Uncontrolled hypertension (\>140/100mmHg)
* Practice of regular moderate to intense physical activity at least 3 day/week
* Not residents of Mexico City or unable to attend to therapy sessions

Where it's running

• Instituto Nacional de Cancerología
  Mexico City, Mexico City, Mexico Recruiting

Study contacts

• Study coordinator: Oscar Arrieta
• Phone: 01 55 56280400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sarcopenia in Patients After Cardiac Surgery

  This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

• Bone marrow mesenchymal stem cell injection for sarcopenia

  This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.

  Recruiting Phase 1/2 GuangZhou Cellgenes Biotechnology Co., Ltd. · Guangzhou · NCT07865676

• GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes

  This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.

  Recruiting Istanbul Saglik Bilimleri University · Istanbul, Kucukcekmece · NCT07858864

• Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis

  We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.

  Recruiting Marmara University · Istanbul, Istanbul · NCT07855419

• Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients

  This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.

  Recruiting Zhangzhou Municipal Hospital · Zhangzhou, Fujian · NCT07836088

• Lower-limb rehabilitation robot training with nutrition education for sarcopenia

  In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.

  Recruiting Taipei Medical University Hospital · Taipei, Taipei City · NCT07830472

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.